# Efficacy of Zoledronic Acid in Osteoporosis

> **NCT03183557** · PHASE2 · UNKNOWN · sponsor: **Shinshu University** · enrollment: 100 (estimated)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** "Zoledronic acid", "Reclast®"
- **DRUG:** "Zoledronic acid", "Reclast®" and "active vitamin D", "alfacalcidol®"

## Key facts

- **NCT ID:** NCT03183557
- **Lead sponsor:** Shinshu University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-12
- **Primary completion:** 2022-12-08
- **Final completion:** 2025-06-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183557, "Efficacy of Zoledronic Acid in Osteoporosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03183557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*